አብዛኛዎቹ ግልጋሎቶች ወደውስጥ ላልገቡ (Login ላላደረጉ) ተጠቃሚዎች ክፍት አይደሉም። በደንብ ለመጠቀም ተመዝግበው ይግቡ።
|ጨረታው የሚዘጋበት ቀን||18 October 2020|
|ጨረታው የሚከፈትበት ቀን||No Specific Opening Date & Time|
Oct 1, 2020 )
|የተለጠፈበት ቀን||Oct 1, 2020|
REQUEST FOR EXPRESSION OF INTEREST (EOI)
Title of the EOI: Re-Launch
Invitation to Manufacturers of Essential Health Products to Submit an Expression of Interest (EOI) For the AfCFTA-anchored Pharma initiative's Pooled Product Evaluation by the United Nations Economic Commission for Africa
DESCRIPTION OF REQUIREMENTS
To maximize the opportunities arising from African Continental Free Trade Area (AfCFTA), African Medicines Agency (AMA) and to realize the objectives of the Pharmaceutical Manufacturing Plan for Africa, the United Nations Economic Commission for Africa (ECA) in collaboration with the African Union Commission (AUC), the African Union Development Agency (AUDA-NEPAD), WHO, UNAIDS and other relevant UN agencies, is commissioning an AfCFTA-anchored pharmaceutical project in select African countries (Seychelles, Madagascar, Comoros, Mauritius, Djibouti, Eritrea, Rwanda anchored by Ethiopia, Kenya, Sudan, and IGAD with a specific aim to bring ideas into action through successful operationalization of the AfCFTA. The AfCFTA anchored Pharma pilot project leverages on the establishment of the AMA and AfCFTA which brings on board a market of 1.3 Billion people, a gross domestic product (GDP) of $2.5 trillion, across 55 member states of the Africa Union (AU). The Agreement is expected to make a significant contribution to Africa's ongoing efforts to materialize the aspirations and goals contained in Agenda 2063 and the 2030 Agenda for Sustainable Development Goals. The AfCFTA-anchored Pharma initiative has a three-pronged approach; localized production; pooled procurement and a harmonized regulatory and quality framework focusing on maternal and child health care (MCH) products to address persistent challenges in MCH burden, unmet needs, and access to reproductive health products across the region but also to the necessity and efficacy of investment in initiatives that address women's health as a key component of inclusive and sustainable economic development. The emphasis on pharmaceuticals is driven by inadequate access to medicines for many infectious and Non Communicable Diseases (NCDs) across Africa as well as the undue strain on both the public and consumer budget. Medicines consume a large proportion of the African nation's healthcare budget. One of the reasons is related to issues of inefficient pharmaceutical procurement models, as well as long lead times for international orders, high transport and distribution costs, poor logistic and storage capacity, limited public finances, and gaps in a global and local production of medicines, among others. These in turn lead to slow progress towards SDGs.
Also, the current supply of medicines to Africans does not meet demand. Africa manufactures "less than 2 percent of the medicines it consumes" while it imports about 70 percent of its needs from outside the continent at an annual cost of $14.5 billion. Specific Instructions and documentation requirements will be sent out after the closing date of this EOI, 18 October 2020 with the Invitation for Pre-qualification document.
UNECA is precluded from entering into a contract with a vendor that is not fully registered with United Nations Global Market lace (UNGM) and did not obtain UN Global Market Place (UNGM) Vendor ID Number. Thus, only those vendors who are registered or provisionally registered or have started their registration process in UNGM will be eligible to receive the solicitation document. (Use https://www.ungm.orgwebsite to register at UNGM:).
Interested vendors who fulfill the requirements are required to submit the completed Vendor Response Form through the address stated above on or before 18 October 2020. Please direct all your queries to the United Nations Economic Commission for Africa using the email provided above.
Vendors interested in participating in this planned solicitation process should complete the Vendor Response Form (Found at UNPD Internet Site: UNPD Internet Site: